Waldenstrom’s Macroglobulinemia (WM): Treatment Progress

Listen Now

Topics Covered

• Overview of Waldenstrom’s Macroglobulinemia, including Staging
• Symptoms & Signs
• Front Line Treatment for WM
• Treatment for Relapsed/Refractory WM
• Current Standard of Care & New Treatment Approaches
• Translating Genomic Findings into New Treatment Opportunities for WM
• Clinical Trials: How Research Contributes to Your Treatment Options
• Controlling Symptoms & Treatment Side Effects, including Reducing Complications
• Peripheral Neuropathy
• Follow-Up Care Appointments & Plans
• Communicating with Your Health Care Team about Your Quality-of-Life
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
• Questions for Our Panel of Experts

Our Panel of Experts

Andrew Branagan, MD, PhD

Attending Physician, Massachusetts General Hospital Cancer Center, Harvard Medical School

Shayna Sarosiek, MD

Physician, Assistant Professor of Medicine, Harvard Medical School, Bing Center for Waldenstrom’s Macroglobulinemia, Dana Farber Cancer Institute

Prashant Kapoor, MD, FACP

Associate Professor of Medicine, Consultant, Division of Hematology, Mayo Clinic

Peter DeNardis

IWMF Chair of the Board of Trustees, The International Waldenstrom’s Macroglobulinemia Foundation (IWMF)

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on May 25, 2022.